ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

ClinicalTrials.gov ID: NCT05949684

Public ClinicalTrials.gov record NCT05949684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) vs Epoetin Alfa for the Treatment of Anemia Due to Revised International Prognostic Scoring System (IPSS-R) Very Low, Low, or Intermediate-Risk Myelodysplastic Syndrome (MDS) in Erythropoiesis-Stimulating Agent (ESA)-Naive Participants Who Are Non-Transfusion Dependent (NTD): The "ELEMENT-MDS" Trial

Study identification

NCT ID
NCT05949684
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

  • Epoetin Alfa Biological
  • Luspatercept Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2023
Primary completion
Jun 24, 2027
Completion
Mar 10, 2030
Last update posted
May 4, 2026

2023 – 2030

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
33
Facility City State ZIP Site status
Local Institution - 0070 Clovis California 93611
Local Institution - 0179 Fountain Valley California 92708
Local Institution - 0211 Los Alamitos California 90720
Local Institution - 0258 Los Angeles California 90095
Local Institution - 0247 Orange California 92868
Local Institution - 0209 Oxnard California 93030
Local Institution - 0183 Walnut Creek California 94598
Local Institution - 0227 Hartford Connecticut 06102
Local Institution - 0173 New Haven Connecticut 06510
Halifax Health Medical Center Daytona Beach Florida 32114
Local Institution - 0202 Fort Myers Florida 33901
Local Institution - 0180 Jacksonville Florida 32207
Local Institution - 0224 Margate Florida 33063
Local Institution - 0163 Plantation Florida 33322
Local Institution - 0201 St. Petersburg Florida 33705
Local Institution - 0238 Tamarac Florida 33321
Local Institution - 0106 Tampa Florida 33612
Local Institution - 0240 Honolulu Hawaii 96813
Local Institution - 0272 Chicago Illinois 60611
Local Institution - 0184 Skokie Illinois 60077
Local Institution - 0270 Dyer Indiana 46311
Local Institution - 0191 Baton Rouge Louisiana 70808
Local Institution - 0044 Covington Louisiana 70433
Local Institution - 0007 Bethesda Maryland 20817
Local Institution - 0222 Saint Louis Park Minnesota 55426
Local Institution - 0128 Hattiesburg Mississippi 39401
Local Institution - 0212 Hackensack New Jersey 07601
Local Institution - 0206 Columbus Ohio 43210
Local Institution - 0174 Knoxville Tennessee 37920
Local Institution - 0228 Houston Texas 77030
Local Institution - 0236 Richmond Virginia 23219
Local Institution - 0229 Roanoke Virginia 24014
Local Institution - 0203 Kennewick Washington 99336

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05949684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05949684 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →